Breaking News

10 hours ago: Scorching Heat Grips Region. Park Forest Opens Cooling Centers.
2 days ago: Community Picnic & Underground Railroad Program at Schubert Woods Pavilion
2 weeks ago: Park Forest’s Sandra Zoellner Retires After 21 Years of Service
2 weeks ago: Save the date for The Prairie Party at theNate
2 weeks ago: Governors State Has New Soccer Complex and New Men’s Coach

Participant Flowin a Randomized Clinical Trial of Hydroxychloroquine vs Placebo in Patients Hospitalized With Respiratory Symptoms of Coronavirus Disease 2019 (COVID-19). (JAMA)

COVID-19, Local, Park Forest, Science

STUDY: Hydroxychloroquine Made No Difference in Patients Hospitalized With COVID-19

by eNews Park Forest on November 9, 2020

eNews Park Forest Author

More in COVID-19:

COVID-19 Uptick: Village Offers Free COVID Testing December 31, 2023
MakeMyTestCount.org: NIH Establishes Website For Self-Reporting COVID-19 Test Results November 22, 2022
Lansing, Illinois Man Sentenced and Ordered to Pay $210,000 in Restitution November 22, 2022

hydroxychoroquine study flow chart — Participant Flowin a Randomized Clinical Trial of Hydroxychloroquine vs Placebo in Patients Hospitalized With Respiratory Symptoms of Coronavirus Disease 2019 (COVID-19). (JAMA)

JAMA-(ENEWSPF)- A study just released by the Journal of the American Medical Association concluded that the once-touted hydroxychloroquine made no significant difference in patients who were hospitalized with COVID-19. The drug made no difference in outcomes of patients regardless of the patients’ age, sex, race/ethnicity, baseline illness severity, and duration of symptoms.